Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: A meta-analysis of randomized controlled trials. This is an ASCO Meeting ...
Long-term outcomes of patients surviving beyond 2 years post–allogeneic stem cell transplantation.
AML: Acute myeloid leukemia; ATG: anti thymocyte globulin; BM: bone marrow; CnI: calcineurin inhibitor; MDS: Myelodysplastic syndrome; MF: myelofibrosis; MTX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback